Reaction
Packed Red Blood Cell Transfusion reporting signals
As of the last recalculation, Packed Red Blood Cell Transfusion appears in 1,324 FAERS reports alongside 34 co-occurring drug terms. The strongest observed disproportionality signal is ECULIZUMAB (PRR 54.8).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Eculizumab | 166 | 54.8 | 54.9 |
| Azacitidine For | 32 | 28.3 | 28.4 |
| Bosentan | 76 | 25.1 | 25.1 |
| Macitentan | 99 | 24.2 | 24.2 |
| Epoprostenol | 19 | 23.1 | 23.2 |
| Metolazone | 16 | 22.6 | 22.7 |
| Selexipag | 34 | 21.2 | 21.2 |
| Sildenafil Powder, | 45 | 20.5 | 20.6 |
| Azacitidine | 33 | 17.9 | 17.9 |
| Riociguat | 34 | 16.8 | 16.8 |
| Venetoclax | 60 | 16.0 | 16.0 |
| Pegaspargase | 12 | 15.5 | 15.6 |
| Apixaban | 63 | 15.5 | 15.5 |
| Hydroxyurea | 19 | 14.3 | 14.3 |
| Sildenafil | 49 | 13.8 | 13.8 |
| Bumetanide | 21 | 12.7 | 12.7 |
| Sofosbuvir | 15 | 12.1 | 12.1 |
| Vincristine Sulfate | 22 | 12.0 | 12.0 |
| Posaconazole Delayed-Release | 8 | 11.5 | 11.5 |
| Micafungin Sodium | 6 | 11.2 | 11.2 |
| Entecavir | 8 | 10.8 | 10.8 |
| Mesna Injection | 5 | 9.5 | 9.5 |
| Mesna | 5 | 9.4 | 9.4 |
| Ifosfamide | 12 | 8.9 | 8.9 |
| Sildenafil Citrate | 68 | 8.8 | 8.8 |
| Doxorubicin Hydrochloride | 18 | 8.8 | 8.8 |
| Etonogestrel And Ethinyl Estradiol | 12 | 8.6 | 8.6 |
| Irinotecan Hydrochloride | 6 | 7.4 | 7.4 |
| Tadalafil | 42 | 6.8 | 6.8 |
| Temozolomide | 9 | 6.8 | 6.8 |
| Nivolumab | 37 | 6.2 | 6.2 |
| Dasatinib | 12 | 5.1 | 5.1 |
| Ravulizumab | 4 | 4.7 | 4.7 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 3 | 4.3 | 4.3 |